var data={"title":"Approach to the patient with elevated serum amylase or lipase","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Approach to the patient with elevated serum amylase or lipase</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/contributors\" class=\"contributor contributor_credentials\">Daniel Gelrud, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/contributors\" class=\"contributor contributor_credentials\">Frank G Gress, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/contributors\" class=\"contributor contributor_credentials\">David C Whitcomb, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/contributors\" class=\"contributor contributor_credentials\">Shilpa Grover, MD, MPH, AGAF</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Feb 03, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Serum amylase and lipase are common tests obtained as biochemical markers for acute pancreatitis. However, the interpretation of these tests can be difficult since several non-pancreatic conditions can present with abnormal serum amylase and lipase levels [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/1,2\" class=\"abstract_t\">1,2</a>]. In addition, some patients with pancreatitis have normal serum amylase and lipase levels when a blood sample is examined [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/3,4\" class=\"abstract_t\">3,4</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-pancreatitis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of acute pancreatitis&quot;</a>.)</p><p>Several factors can influence serum amylase and lipase levels.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The levels depend upon the rate of production from different tissues and the rate of clearance. As an example, serum amylase and lipase levels may be elevated in patients with renal failure. (See <a href=\"topic.htm?path=serum-enzymes-in-patients-with-renal-failure\" class=\"medical medical_review\">&quot;Serum enzymes in patients with renal failure&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Organs other than the pancreas can produce these enzymes. Alcoholics, for example, may have an elevated serum amylase of salivary origin. The most commonly used amylase assays cannot differentiate between salivary and pancreatic amylase.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Certain serum factors influence amylase and lipase enzyme activity. As an example, patients with pancreatitis due to hypertriglyceridemia may appear to have normal amylase levels, most likely due to a circulating factor that inhibits the enzyme's activity [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/5\" class=\"abstract_t\">5</a>].</p><p/><p>This topic review will present an approach the patient with an elevated serum amylase or lipase. Elevation of these measures in the context of individual disorders (such as pancreatitis) is discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-pancreatitis#H367341716\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of acute pancreatitis&quot;, section on 'Pancreatic enzymes and products'</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">AMYLASE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Amylase is derived from the Greek word &quot;amylone,&quot; which means starch. The main sources of amylase in humans are the pancreas and salivary glands, but it can be found in other tissues in small quantities [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/6\" class=\"abstract_t\">6</a>]. The main function of amylase is to cleave starch into smaller polysaccharides at the internal 1 to 4 alpha linkage in the process of digestion.</p><p>Several isoforms of amylase can be identified by electrophoresis; the most abundant are the P form derived from the pancreas and the S form of salivary origin [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/6\" class=\"abstract_t\">6</a>]. The molecular weight of the isoforms is relatively small (about 50,000 Daltons) so they can be filtered by the kidneys [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/6\" class=\"abstract_t\">6</a>]. Amylase is excreted by the reticuloendothelial system (75 percent) and the kidneys (25 percent). There are multiple methods for measuring serum amylase activity. The results are usually reported in Somogyi units (SU) or international units (IU). The normal values depend upon the assay used since the tests used vary by hospital.</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Macroamylase</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Serum amylase levels may be elevated in settings in which amylase is bound to other macromolecules like immunoglobulins and polysaccharides, forming complexes known as macroamylase [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/7\" class=\"abstract_t\">7</a>]. Because of the size of these complexes, renal excretion is reduced and the amylase level as measured by serologic tests is increased. Such patients typically have chronically elevated serum amylase levels, although the degree of elevation can fluctuate [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/8\" class=\"abstract_t\">8</a>].</p><p>Several diseases have been described in association with macroamylasemia, including celiac disease, HIV infection, lymphoma, ulcerative colitis, rheumatoid arthritis, and monoclonal gammopathy [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/8-17\" class=\"abstract_t\">8-17</a>]. Macroamylasemia may resolve in patients with celiac disease following a gluten-free diet [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/9,17\" class=\"abstract_t\">9,17</a>]. Celiac disease has also been associated with elevation in serum amylase (as well as other pancreatic enzymes) without macroamylasemia [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/18\" class=\"abstract_t\">18</a>]. Elevated levels are generally less than two-fold the upper limit of normal.</p><p>The diagnosis of macroamylasemia can be established by determining the molecular weight of the serum amylase or by immunologic assays. The amylase-to-creatinine clearance ratio can also be suggestive (see <a href=\"#H10\" class=\"local\">'Amylase-to-creatinine clearance ratio (ACCR)'</a> below).</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Causes of elevated serum amylase</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are many conditions and drugs associated with an elevated amylase (<a href=\"image.htm?imageKey=GAST%2F63497\" class=\"graphic graphic_table graphicRef63497 \">table 1</a> and <a href=\"image.htm?imageKey=GAST%2F64829\" class=\"graphic graphic_table graphicRef64829 \">table 2</a>). The cause of the elevated amylase in some of these conditions is incompletely understood. Some of these conditions have similar clinical features further complicating interpretation of serum amylase levels.</p><p>As an example, patients with severe gastroenteritis may have serum amylase levels up to 2.2 times the upper limit of normal, a situation that may cause confusion in those presenting with abdominal pain [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/19\" class=\"abstract_t\">19</a>]. Hyperamylasemia may also present in patients with acute liver failure due mainly to coexisting renal dysfunction but cause confusion as to the presence of coexisting pancreatitis [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/20\" class=\"abstract_t\">20</a>]. To further complicate matters, there are no good gold standards for several of these conditions. One example is pancreatitis. It is well recognized that patients with severe pancreatitis commonly have normal serum amylase levels [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/2,21,22\" class=\"abstract_t\">2,21,22</a>], particularly in patients with pancreatitis related to hypertriglyceridemia [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/23\" class=\"abstract_t\">23</a>] and ethanol [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/3,22,24\" class=\"abstract_t\">3,22,24</a>].</p><p>Despite the lack of specificity, the predictive values of serum amylase determinations are influenced by the clinical context in which they are measured. An elevated amylase level, for example, most likely indicates the presence of pancreatitis in patients who present with the classic symptoms and typical radiologic findings of pancreatitis. The pattern of amylase elevation can be helpful in determining the etiology of the pancreatitis. Patients with gallstone pancreatitis tend to have higher amylase and lipase levels than patients with pancreatitis of other etiology. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-pancreatitis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of acute pancreatitis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h1\">LIPASE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are several lipases in the human body, including lingual, pancreatic, lipoprotein, intestinal, and hepatic lipase. Activity of all the lipases is inhibited by bile acids. The activity of pancreatic lipase depends upon the presence of another enzyme, colipase, which facilitates attachment to triglyceride droplets and prevents bile salts from deactivating pancreatic lipase (see <a href=\"topic.htm?path=mechanisms-of-nutrient-absorption-and-malabsorption\" class=\"medical medical_review\">&quot;Mechanisms of nutrient absorption and malabsorption&quot;</a>). One of the commonly used assays for pancreatic lipase takes advantage of this property; bile acids and colipase are added to the assay to inhibit all lipases other than pancreatic lipase, thus providing a specific assay for pancreatic lipase.</p><p>The main function of the pancreatic lipase is to hydrolyze triglycerides into glycerol and free fatty acids. Like amylase, lipase is a relatively small molecule that can be filtrated by the kidney. Unlike amylase, lipase can be reabsorbed in the renal tubules, which increases its half-life (6.9 to 13.7 hours).</p><p class=\"headingAnchor\" id=\"H1151735618\"><span class=\"h2\">Causes of elevated serum lipase</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Lipase is elevated in patients with renal failure and can also be elevated in several other conditions other than pancreatitis (<a href=\"image.htm?imageKey=GAST%2F77323\" class=\"graphic graphic_table graphicRef77323 \">table 3</a> and <a href=\"image.htm?imageKey=GAST%2F77633\" class=\"graphic graphic_table graphicRef77633 \">table 4</a>). Between 11 and 12.5 percent of patients admitted to the hospital with non-pancreatic abdominal pain have an elevated serum lipase [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/1,2\" class=\"abstract_t\">1,2</a>]. Up to 24 percent of patients with diabetic ketoacidosis have non-specific elevations of lipase [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/25\" class=\"abstract_t\">25</a>]. In a group of asymptomatic HIV positive patients, 60 percent had an abnormal amylase or lipase measurement on at least one occasion [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/26\" class=\"abstract_t\">26</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">APPROACH TO THE PATIENT WITH AN ELEVATED AMYLASE OR LIPASE</span></p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Clinical history</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most important step in the evaluation of patients with elevation in the serum amylase or lipase level is to obtain a detailed history and physical examination. Asymptomatic patients should be thoroughly screened for conditions like macroamylasemia, chronic alcohol abuse, renal failure, pancreatic cancer, and other non-pancreatic conditions (<a href=\"image.htm?imageKey=GAST%2F63497\" class=\"graphic graphic_table graphicRef63497 \">table 1</a> and <a href=\"image.htm?imageKey=GAST%2F77323\" class=\"graphic graphic_table graphicRef77323 \">table 3</a>).</p><p>Several additional diagnoses should be considered in patients who have these enzyme elevations in the setting of abdominal pain. The enzymes can be interpreted in many ways depending upon the clinical settings.</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Repeating the test</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Persistent elevation in pancreatic enzyme levels should be confirmed by repeated testing. However, for reasons that are unclear, pancreatic enzymes levels (including amylase, isoamylase, lipase and trypsin) fluctuate daily (and may return to the normal range) in patients who have benign causes of pancreatic hyperenzymemia [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/27\" class=\"abstract_t\">27</a>]. Thus, several observations may be required to document the persistent elevation. One study suggested that documentation of such fluctuations may support the diagnosis of benign causes of hyperenzymemia [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/27\" class=\"abstract_t\">27</a>]. However, there are no direct studies that have demonstrated whether such fluctuations correlate with benign causes.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Amylase or lipase alone</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>As discussed above, elevation in the serum amylase or lipase can be caused by non-pancreatic disease. In patients with pancreatitis, both amylase and lipase rise early on presentation, but amylase may return to normal before serum lipase because of its shorter half-life and increased renal clearance [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/5\" class=\"abstract_t\">5</a>]. Amylase and lipase levels do not correlate with the severity of pancreatitis [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/4\" class=\"abstract_t\">4</a>] and therefore are not included in any of the several prognostic scores [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/28,29\" class=\"abstract_t\">28,29</a>]. It is important to also note that both amylase and lipase can be normal in the setting of acute pancreatitis [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/30\" class=\"abstract_t\">30</a>].</p><p>The sensitivity and specificity of amylase and lipase for pancreatitis depend upon the threshold for an abnormal result. Higher thresholds are associated with better specificity but lower sensitivity. Several studies suggest that lipase may be more specific than amylase in the diagnosis of acute pancreatitis [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/31,32\" class=\"abstract_t\">31,32</a>]. A lipase level of three times the upper limit of normal is approximately 98 percent specific for acute pancreatitis [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/31-33\" class=\"abstract_t\">31-33</a>].</p><p>While a general approach to patients with an elevated amylase level has been outlined (<a href=\"image.htm?imageKey=GAST%2F57456\" class=\"graphic graphic_algorithm graphicRef57456 \">algorithm 1</a>), the specific order and nature of testing may vary depending upon the clinical setting.</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Amylase-to-creatinine clearance ratio (ACCR)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Calculation of the ratio of the clearance of amylase to the clearance of creatinine is primarily of value in patients with macroamylasemia [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/34\" class=\"abstract_t\">34</a>]. In this setting, the ratio is reduced because of poor filtration of the large macroamylase complexes. A ratio less than 1 percent on a 24 hour collection strongly supports the diagnosis. </p><p>An increase in the ACCR has been used to diagnose acute pancreatitis. The ratio is increased in the setting of acute pancreatitis but is not more helpful than serum amylase determinations alone [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/35\" class=\"abstract_t\">35</a>]. Hyperamylasuria occurs in acute pancreatitis because the ACCR increases from 3 to approximately 10 percent [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/35\" class=\"abstract_t\">35</a>]. However, even moderate renal insufficiency interferes with accuracy of the ACCR. Furthermore, an increase in the ACCR is not specific to acute pancreatitis since it also occurs in patients with severe burns or diabetic ketoacidosis [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/36\" class=\"abstract_t\">36</a>]. (See <a href=\"topic.htm?path=serum-enzymes-in-patients-with-renal-failure\" class=\"medical medical_review\">&quot;Serum enzymes in patients with renal failure&quot;</a> and <a href=\"topic.htm?path=diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis\" class=\"medical medical_review\">&quot;Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Clinical features, evaluation, and diagnosis&quot;</a>.)</p><p>The ratio is measured by the following formula:</p><div class=\"formulaContainer\"><div class=\"formula\"><p class=\"bulletIndent1\">ACCR = &#160;Amylase(urine) x Creatinine(serum) x 100<br/> &#160; &#160; &#160; &#160; &#160; &#160;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;<br/> &#160; &#160; &#160; &#160; &#160; &#160; Amylase(serum) x Creatinine(urine)</p></div></div><p/><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Lipase-to-amylase ratio</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Some reports have suggested that a serum lipase-to-amylase ratio of greater than two can be used to differentiate between alcoholic and nonalcoholic acute pancreatitis [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/37,38\" class=\"abstract_t\">37,38</a>]. However, these observations were not confirmed in later studies [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/39,40\" class=\"abstract_t\">39,40</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Imaging studies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Imaging studies are important for evaluating patients with an elevated amylase or lipase who have abdominal pain [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/5\" class=\"abstract_t\">5</a>]. A computed tomography (CT) scan with thin cuts through the pancreas or magnetic resonance imaging <span class=\"nowrap\">(MRI)/magnetic</span> resonance cholangiopancreatogram (MRCP) should also be considered in the setting of a high amylase or lipase level when the diagnosis is uncertain.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>CT scan with thin cuts through the pancreas is of greatest value because it can detect a variety of pathologic conditions that can cause an elevated serum amylase and lipase. However, a CT scan was found to be negative in up to 30 percent of patients with acute pancreatitis in older studies [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/41,42\" class=\"abstract_t\">41,42</a>]. Some animal and human studies have suggested that the outcomes of patients with severe pancreatitis may be worse when receiving intravenous contrast in the first 24 hours after the onset of acute pancreatitis [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/43\" class=\"abstract_t\">43</a>]. Thus, the timing of CT should be considered in the clinical setting. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Magnetic resonance imaging (MRI) and magnetic resonance cholangiopancreatogram (MRCP) are increasingly being used in the diagnosis and management of acute pancreatitis. MRCP, both enhanced and non-enhanced, has a strong correlation with contrast-enhanced CT in acute pancreatitis [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/44\" class=\"abstract_t\">44</a>]. The advantages of MRI over CT include: lower risk of nephrotoxicity from gadolinium in patients without underlying renal disease, ability of MRI to better categorize fluid collections as acute fluid collections, necrosis, abscess, hemorrhage, and pseudocyst [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/45\" class=\"abstract_t\">45</a>], and the greater sensitivity of MRI to detect mild acute pancreatitis compared with CT.&nbsp;In addition, unlike CT, MRCP delineates the pancreatic and bile ducts better, and MRCP is comparable to endoscopic retrograde cholangiopancreatography (ERCP) for the detection of choledocholithiasis [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/46\" class=\"abstract_t\">46</a>]. In one report, MRI was reliable for staging the severity of AP, had prognostic value, was associated with fewer contraindications compared with CT, and was able to detect pancreatic duct disruptions [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/47\" class=\"abstract_t\">47</a>].<br/><br/>Abdominal imaging using MRI is rapidly evolving both in terms of technology (hardware and software) as well as the protocols used for imaging (pulse sequences, contrast agents, use of breath-holding, etc). This has made abdominal MRI operator-dependent with consequent variability in quality and technique. Its use in acute pancreatitis should currently be dictated by local expertise and availability.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Plain abdominal films are useful to diagnose a perforated viscus. The findings in acute pancreatitis are non-specific.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Abdominal ultrasonography is of limited value because the pancreas cannot be properly studied in up to 40 percent of patients due to intervening layers of muscle and fat or bowel gas [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/5\" class=\"abstract_t\">5</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>ERCP and endoscopic ultrasound are of limited value in the diagnosis of acute pancreatitis. On the other hand, they can be helpful in the diagnosis of suspected gallstone pancreatitis, chronic pancreatitis, and in patients suspected of having an occult pancreatic malignancy. (See appropriate topic reviews.)</p><p/><p class=\"headingAnchor\" id=\"H13\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The interpretation of a high amylase or lipase can be complex.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The clinical history is critical. Asymptomatic patients should be thoroughly screened for conditions like macroamylasemia, chronic alcohol abuse, renal failure, pancreatic cancer, and other non-pancreatic conditions (<a href=\"image.htm?imageKey=GAST%2F63497\" class=\"graphic graphic_table graphicRef63497 \">table 1</a> and <a href=\"image.htm?imageKey=GAST%2F64829\" class=\"graphic graphic_table graphicRef64829 \">table 2</a>). Several additional diagnoses should be considered in patients who have these enzyme elevations in the setting of abdominal pain. (See <a href=\"#H4\" class=\"local\">'Causes of elevated serum amylase'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Serum lipase values are more specific than serum amylase levels in patients suspected of having acute pancreatitis. Pancreatitis is almost always present when enzyme levels measure three times the upper limit of normal. (See <a href=\"#H1151735618\" class=\"local\">'Causes of elevated serum lipase'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>While a general approach to patients with an elevated amylase level has been outlined (<a href=\"image.htm?imageKey=GAST%2F57456\" class=\"graphic graphic_algorithm graphicRef57456 \">algorithm 1</a>), the specific order and nature of testing may vary depending upon the clinical setting. (See <a href=\"#H6\" class=\"local\">'Approach to the patient with an elevated amylase or lipase'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A computed tomography scan with thin cuts through the pancreas or magnetic resonance <span class=\"nowrap\">imaging/magnetic</span> resonance cholangiopancreatogram is helpful in the setting of a high amylase or lipase level when the diagnosis is uncertain. (See <a href=\"#H12\" class=\"local\">'Imaging studies'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/1\" class=\"nounderline abstract_t\">Chase CW, Barker DE, Russell WL, Burns RP. Serum amylase and lipase in the evaluation of acute abdominal pain. Am Surg 1996; 62:1028.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/2\" class=\"nounderline abstract_t\">Gumaste VV, Roditis N, Mehta D, Dave PB. Serum lipase levels in nonpancreatic abdominal pain versus acute pancreatitis. Am J Gastroenterol 1993; 88:2051.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/3\" class=\"nounderline abstract_t\">Clavien PA, Robert J, Meyer P, et al. Acute pancreatitis and normoamylasemia. Not an uncommon combination. Ann Surg 1989; 210:614.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/4\" class=\"nounderline abstract_t\">Lankisch PG, Burchard-Reckert S, Lehnick D. Underestimation of acute pancreatitis: patients with only a small increase in amylase/lipase levels can also have or develop severe acute pancreatitis. Gut 1999; 44:542.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/5\" class=\"nounderline abstract_t\">Fallat RW, Vester JW, Glueck CJ. Suppression of amylase activity by hypertriglyceridemia. JAMA 1973; 225:1331.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/6\" class=\"nounderline abstract_t\">Pieper-Bigelow C, Strocchi A, Levitt MD. Where does serum amylase come from and where does it go? Gastroenterol Clin North Am 1990; 19:793.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/7\" class=\"nounderline abstract_t\">Berk JE, Kizu H, Wilding P, Searcy RL. Macroamylasemia: a newly recognized cause for elevated serum amylase activity. N Engl J Med 1967; 277:941.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/8\" class=\"nounderline abstract_t\">Sachdeva CK, Bank S, Greenberg R, et al. Fluctuations in serum amylase in patients with macroamylasemia. Am J Gastroenterol 1995; 90:800.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/9\" class=\"nounderline abstract_t\">Deprettere AJ, Eykens A, Van Hoof V. Disappearance of macroamylasemia in a celiac patient after treatment with a gluten-free diet. J Pediatr Gastroenterol Nutr 2001; 33:346.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/10\" class=\"nounderline abstract_t\">Barera G, Bazzigaluppi E, Viscardi M, et al. Macroamylasemia attributable to gluten-related amylase autoantibodies: a case report. Pediatrics 2001; 107:E93.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/11\" class=\"nounderline abstract_t\">Rabsztyn A, Green PH, Berti I, et al. Macroamylasemia in patients with celiac disease. Am J Gastroenterol 2001; 96:1096.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/12\" class=\"nounderline abstract_t\">Eleccion CB, Hathaway AA. Macroamylasemia in HIV infection. Tex Med 1998; 94:77.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/13\" class=\"nounderline abstract_t\">Bonetti G, Serricchio G, Giudici A, et al. Hyperamylasemia due to macroamylasemia in adult gluten enteropathy. Scand J Clin Lab Invest 1997; 57:271.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/14\" class=\"nounderline abstract_t\">Yoshida K, Minegishi Y, Okawa H, et al. Epstein-Barr virus-associated malignant lymphoma with macroamylasemia and monoclonal gammopathy in a patient with Wiskott-Aldrich syndrome. Pediatr Hematol Oncol 1997; 14:85.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/15\" class=\"nounderline abstract_t\">Cutolo M, Sulli A, Barone A, et al. Macroamylasemia: a possible cause of unexplained hyperamylasemia in rheumatoid arthritis. Br J Rheumatol 1995; 34:290.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/16\" class=\"nounderline abstract_t\">Fujimura Y, Nishishita C, Uchida J, Iida M. Macroamylasemia associated with ulcerative colitis. J Mol Med (Berl) 1995; 73:95.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/17\" class=\"nounderline abstract_t\">Van Gossum A, Cremer M. Macroamylasemia disappearance after gluten withdrawal. Dig Dis Sci 1989; 34:964.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/18\" class=\"nounderline abstract_t\">Carroccio A, Di Prima L, Scalici C, et al. Unexplained elevated serum pancreatic enzymes: a reason to suspect celiac disease. Clin Gastroenterol Hepatol 2006; 4:455.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/19\" class=\"nounderline abstract_t\">Ben-Horin S, Farfel Z, Mouallem M. Gastroenteritis-associated hyperamylasemia: prevalence and clinical significance. Arch Intern Med 2002; 162:689.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/20\" class=\"nounderline abstract_t\">Cot&eacute; GA, Gottstein JH, Daud A, et al. The role of etiology in the hyperamylasemia of acute liver failure. Am J Gastroenterol 2009; 104:592.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/21\" class=\"nounderline abstract_t\">Clavien PA, Burgan S, Moossa AR. Serum enzymes and other laboratory tests in acute pancreatitis. Br J Surg 1989; 76:1234.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/22\" class=\"nounderline abstract_t\">Spechler SJ, Dalton JW, Robbins AH, et al. Prevalence of normal serum amylase levels in patients with acute alcoholic pancreatitis. Dig Dis Sci 1983; 28:865.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/23\" class=\"nounderline abstract_t\">Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am 1990; 19:783.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/24\" class=\"nounderline abstract_t\">Orebaugh SL. Normal amylase levels in the presentation of acute pancreatitis. Am J Emerg Med 1994; 12:21.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/25\" class=\"nounderline abstract_t\">Yadav D, Nair S, Norkus EP, Pitchumoni CS. Nonspecific hyperamylasemia and hyperlipasemia in diabetic ketoacidosis: incidence and correlation with biochemical abnormalities. Am J Gastroenterol 2000; 95:3123.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/26\" class=\"nounderline abstract_t\">Argiris A, Mathur-Wagh U, Wilets I, Mildvan D. Abnormalities of serum amylase and lipase in HIV-positive patients. Am J Gastroenterol 1999; 94:1248.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/27\" class=\"nounderline abstract_t\">Gullo L. Day-to-day variations of serum pancreatic enzymes in benign pancreatic hyperenzymemia. Clin Gastroenterol Hepatol 2007; 5:70.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/28\" class=\"nounderline abstract_t\">Ranson JH, Pasternack BS. Statistical methods for quantifying the severity of clinical acute pancreatitis. J Surg Res 1977; 22:79.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/29\" class=\"nounderline abstract_t\">Ranson JH. Etiological and prognostic factors in human acute pancreatitis: a review. Am J Gastroenterol 1982; 77:633.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/30\" class=\"nounderline abstract_t\">Shah AM, Eddi R, Kothari ST, et al. Acute pancreatitis with normal serum lipase: a case series. JOP 2010; 11:369.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/31\" class=\"nounderline abstract_t\">Steinberg WM, Goldstein SS, Davis ND, et al. Diagnostic assays in acute pancreatitis. A study of sensitivity and specificity. Ann Intern Med 1985; 102:576.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/32\" class=\"nounderline abstract_t\">Tietz NW, Huang WY, Rauh DF, Shuey DF. Laboratory tests in the differential diagnosis of hyperamylasemia. Clin Chem 1986; 32:301.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/33\" class=\"nounderline abstract_t\">Werner M, Steinberg WM, Pauley C. Strategic use of individual and combined enzyme indicators for acute pancreatitis analyzed by receiver-operator characteristics. Clin Chem 1989; 35:967.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/34\" class=\"nounderline abstract_t\">Levitt MD. Clinical use of amylase clearance and isoamylase measurements. Mayo Clin Proc 1979; 54:428.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/35\" class=\"nounderline abstract_t\">Johnson SG, Ellis CJ, Levitt MD. Mechanism of increased renal clearnace of amylase/creatinine in acute pancreatitis. N Engl J Med 1976; 295:1214.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/36\" class=\"nounderline abstract_t\">Levine RI, Glauser FL, Berk JE. Enhancement of the amylase-creatinine clearance ratio in disorders other than acute pancreatitis. N Engl J Med 1975; 292:329.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/37\" class=\"nounderline abstract_t\">Gumaste VV, Dave PB, Weissman D, Messer J. Lipase/amylase ratio. A new index that distinguishes acute episodes of alcoholic from nonalcoholic acute pancreatitis. Gastroenterology 1991; 101:1361.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/38\" class=\"nounderline abstract_t\">Tenner SM, Steinberg W. The admission serum lipase:amylase ratio differentiates alcoholic from nonalcoholic acute pancreatitis. Am J Gastroenterol 1992; 87:1755.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/39\" class=\"nounderline abstract_t\">King LG, Seelig CB, Ranney JE. The lipase to amylase ratio in acute pancreatitis. Am J Gastroenterol 1995; 90:67.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/40\" class=\"nounderline abstract_t\">Sadowski DC, Sutherland LR. The lipase/amylase ratio: sensitive but not specific. Gastroenterology 1992; 103:352.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/41\" class=\"nounderline abstract_t\">Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990; 174:331.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/42\" class=\"nounderline abstract_t\">Balthazar EJ. CT diagnosis and staging of acute pancreatitis. Radiol Clin North Am 1989; 27:19.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/43\" class=\"nounderline abstract_t\">McMenamin DA, Gates LK Jr. A retrospective analysis of the effect of contrast-enhanced CT on the outcome of acute pancreatitis. Am J Gastroenterol 1996; 91:1384.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/44\" class=\"nounderline abstract_t\">Lecesne R, Taourel P, Bret PM, et al. Acute pancreatitis: interobserver agreement and correlation of CT and MR cholangiopancreatography with outcome. Radiology 1999; 211:727.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/45\" class=\"nounderline abstract_t\">Morgan DE, Baron TH, Smith JK, et al. Pancreatic fluid collections prior to intervention: evaluation with MR imaging compared with CT and US. Radiology 1997; 203:773.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/46\" class=\"nounderline abstract_t\">Taylor AC, Little AF, Hennessy OF, et al. Prospective assessment of magnetic resonance cholangiopancreatography for noninvasive imaging of the biliary tree. Gastrointest Endosc 2002; 55:17.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-elevated-serum-amylase-or-lipase/abstract/47\" class=\"nounderline abstract_t\">Arvanitakis M, Delhaye M, De Maertelaere V, et al. Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis. Gastroenterology 2004; 126:715.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 5643 Version 12.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H13\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">AMYLASE</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Macroamylase</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Causes of elevated serum amylase</a></li></ul></li><li><a href=\"#H5\" id=\"outline-link-H5\">LIPASE</a><ul><li><a href=\"#H1151735618\" id=\"outline-link-H1151735618\">Causes of elevated serum lipase</a></li></ul></li><li><a href=\"#H6\" id=\"outline-link-H6\">APPROACH TO THE PATIENT WITH AN ELEVATED AMYLASE OR LIPASE</a><ul><li><a href=\"#H7\" id=\"outline-link-H7\">Clinical history</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Repeating the test</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Amylase or lipase alone</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">Amylase-to-creatinine clearance ratio (ACCR)</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">Lipase-to-amylase ratio</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Imaging studies</a></li></ul></li><li><a href=\"#H13\" id=\"outline-link-H13\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"GAST/5643|ALG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"ALGORITHMS\">ALGORITHMS</a></div><ul><li><a href=\"image.htm?imageKey=GAST/57456\" class=\"graphic graphic_algorithm\">- Approach to patients with an elevated serum amylase</a></li></ul></li><li><div id=\"GAST/5643|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/63497\" class=\"graphic graphic_table\">- Conditions associated with a high serum amylase</a></li><li><a href=\"image.htm?imageKey=GAST/64829\" class=\"graphic graphic_table\">- Drugs affecting serum amylase</a></li><li><a href=\"image.htm?imageKey=GAST/77323\" class=\"graphic graphic_table\">- Conditions associated with a high serum lipase</a></li><li><a href=\"image.htm?imageKey=GAST/77633\" class=\"graphic graphic_table\">- Drugs affecting serum lipase values</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-pancreatitis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of acute pancreatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-clinical-features-evaluation-and-diagnosis\" class=\"medical medical_review\">Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Clinical features, evaluation, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mechanisms-of-nutrient-absorption-and-malabsorption\" class=\"medical medical_review\">Mechanisms of nutrient absorption and malabsorption</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=serum-enzymes-in-patients-with-renal-failure\" class=\"medical medical_review\">Serum enzymes in patients with renal failure</a></li></ul></div></div>","javascript":null}